Bardoxolone methyl exerts an inhibitory effect on respiratory syncytial virus infection by downregulating IL-6 via the IKKβ/NF-κB signaling pathway
Microbiology Spectrum · 03.11.2026 · 14 (11)
DOI: 10.1128/spectrum.03825-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Xunping Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Guizhou University, Guiyang, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, I-kappa B Kinase, Interleukin-6, Signal Transduction. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Respiratory Critical Disease Clinical Research and Prevention and Treatment Talent Base Project, National Natural Science Foundation of China, Health Commission of Guizhou Provincial.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) causes severe lower respiratory tract infections in infants, older adults, and immunocompromised individuals, but therapeutic options for active infection remain limited. Interleukin-6 (IL-6) contributes to RSV replication and RSV-induced inflammation, and the IKKβ/NF-κB pathway is a major regulator of IL-6 expression. Bardoxolone methyl (BXM) was identified by network medicine as a potential anti-RSV compound, with molecular docking suggesting interactions with the IKKβ/NF-κB pathway. We investigated whether BXM inhibits RSV infection through modulation of the IKKβ/NF-κB/IL-6 axis in RSV-infected BEAS-2B cells and BALB/c mice. RSV infection increased IL-6 expression and activated IKKβ/NF-κB signaling, whereas IL-6 knockdown reduced viral replication and inflammatory mediator expression. BXM significantly suppressed RSV replication, as shown by RT-qPCR, TCID₅₀, plaque reduction assays, and Western blotting, and decreased IL-6 expression in vitro . Mechanistically, BXM attenuated RSV-induced phosphorylation of IKKβ and NF-κB. The IKKβ inhibitor TPCA-1 produced similar inhibitory effects, whereas recombinant human IL-6 add-back partially restored inflammatory mediator expression in BXM-treated RSV-infected cells. In mice, BXM reduced lung viral titers, RSV-F expression, IL-6 expression, IKKβ/NF-κB activation, and RSV-induced lung injury. These findings suggest that BXM suppresses RSV replication and inflammation, at least in part, by modulating the IKKβ/NF-κB/IL-6 axis, supporting its potential as a therapeutic candidate for RSV infection. IMPORTANCE Respiratory syncytial virus (RSV) is a major cause of respiratory illness, especially in infants, older adults, and people with weakened immune systems. Although preventive strategies are available for some high-risk groups, treatment options for active RSV infection remain limited. This study identifies bardoxolone methyl (BXM) as a potential anti-RSV compound and shows that it can reduce both viral replication and virus-induced inflammation in cell and mouse models. Importantly, our findings suggest that BXM acts, at least in part, by reducing IL-6-related inflammatory signaling, which is closely associated with RSV disease severity. These results provide experimental evidence supporting BXM as a promising candidate for further development against RSV infection and offer insight into a potential host-targeted therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Guizhou University, Guiyang, China.
- National Health Commission Key Laboratory for Diagnosis and Treatment of Pulmonary Immune Diseases, Guiyang, China.
- Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, China.
- Department of Respiratory and Critical Care Medicine, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China.
- Department of Clinical Medicine, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
- Department of Clinical Medicine, Zunyi Medical University, Zunyi, China.
ORCID-Profile: Xunping Wu, Daishun Liu
Förderung
- Guizhou Provincial Respiratory Critical Disease Clinical Research and Prevention and Treatment Talent Base Project
- National Natural Science Foundation of China
- Health Commission of Guizhou Provincial
- Science and Technology Project of Guizhou Province
- Science and Technology Bureau of Zunyi
Zitieren
APA
Wu, X., Wang, H., Zhang, L., Wang, B., Tan, X., Li, Z., Nie, J., & Liu, D. (2026). Bardoxolone methyl exerts an inhibitory effect on respiratory syncytial virus infection by downregulating IL-6 via the IKKβ/NF-κB signaling pathway. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.03825-25
Vancouver
Wu X, Wang H, Zhang L, Wang B, Tan X, Li Z, et al. Bardoxolone methyl exerts an inhibitory effect on respiratory syncytial virus infection by downregulating IL-6 via the IKKβ/NF-κB signaling pathway. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.03825-25
BibTeX
@article{Wu2026,
author = {Wu, Xunping and Wang, Hongping and Zhang, Ling and Wang, Bingyao and Tan, Xinran and Li, Zhu and Nie, Jin and Liu, Daishun},
title = {Bardoxolone methyl exerts an inhibitory effect on respiratory syncytial virus infection by downregulating IL-6 via the IKKβ/NF-κB signaling pathway},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {11},
doi = {10.1128/spectrum.03825-25}
}
EUVIMED